Advertisement
Screener

PALISADE BIO, INC. (PALI) Other

PALISADE BIO, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-20: Form 10-K; Item Stock registered under Section 12(b); As filed common stock, $0.01 par value · PALI · NASDAQ.
  • 2025-03-24: Form 10-K; Item Stock registered under Section 12(b); As filed common stock, $0.01 par value · PALI · NASDAQ.
  • 2021-08-23: Form 10-Q; Item Shares outstanding as of 2021-08-20; As filed 11,398,698.
  • 2021-05-14: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.01 par value · pali.
FiledFormItemAs filed
2026-03-2010-KStock registered under Section 12(b)common stock, $0.01 par value · PALI · NASDAQ
2025-03-2410-KStock registered under Section 12(b)common stock, $0.01 par value · PALI · NASDAQ
2021-08-2310-QShares outstanding as of 2021-08-2011,398,698
2021-05-1410-QStock registered under Section 12(b)Common Stock, $0.01 par value · pali
2021-03-2210-KStock registered under Section 12(b)Common Stock, $0.01 par value · snca
2020-11-1010-QStock registered under Section 12(b)Common Stock, $0.01 par value · snca
2020-08-1310-QStock registered under Section 12(b)Common Stock, $0.01 par value · snca
2020-05-1510-QStock registered under Section 12(b)Common Stock, $0.01 par value · snca
2020-03-2710-KStock registered under Section 12(b)Common Stock, $0.01 par value · snca
2019-11-1410-QStock registered under Section 12(b)Common Stock, $0.01 par value · cur
2019-08-1410-QStock registered under Section 12(b)Common Stock · cur

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Liminatus Pharma, Inc. (LIMN)United States$0.282B
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35